Overview

Price chart · mood · technical indicators

NEPH

Nephros Incstock Healthcare

Medical Instruments & Supplies

$3.0770.56%Current Market Mood:Bearish

Market Mood

Price Range (1Y)

$1.78$6.42

Current: $3.07

Idea: SMA

1Y Return

+59.6%

Sharpe 3Y

0.58

Market Comparison

vs Healthcare Sector & Medical Instruments & Supplies Industry

NEPH

+70.56%

1Y Performance

Healthcare

Sector 1Y

Medical Instruments & Supplies

Industry 1Y

Fundamentals

Updated daily after market close

P/E ratio28.27

EPS (TTM)$0.11-82.4% YoY

Profit margin6.4%HEALTHCARE

Market cap$33.1MMicro cap

Valuation

Forward P/E: —
PEG ratio: 0.00
P/B: 3.25
P/S (TTM): 1.76
EV/EBITDA: 21.36

Profitability & growth

ROE (TTM): 12.7%
Operating margin: 0.4%
Revenue growth YoY: 22.2%
Dividend yield: —
Beta: 1.56

Last earnings

Mar 5, 2026 · Estimate $-0.01 · Reported $0.01

Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

50 articles · sorted by date

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Nephros Inc

Company profile

Nephros, Inc., a commercial stage company, develops and sells water solutions to the medical and commercial markets in the United States. The company is headquartered in South Orange, New Jersey.

Classification

Sector: Healthcare
Industry: Medical Instruments & Supplies
Exchange: NASDAQ
Country: USA
Currency: USD

Company profile

HQ: 380 LACKAWANNA PLACE, SOUTH ORANGE, NJ
Fiscal year end: December
Latest quarter: Dec 31, 2025

Market cap$33.1M

Shares outstanding$10.6M

52W high$6.42

52W low$1.78

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer

Overview

NEPH

Market Comparison

Fundamentals

Valuation

Profitability & growth

News & Sentiment

Nephros to Report First Quarter 2026 Financial Results on May 7

Nephros | 10-K/A: Annual report (Amendment)

Nephros schedules Q1 results after close, investor call at 4:30 ET

Nephros Schedules First Quarter 2026 Financial Results Conference Call

NEPHROS INC Amends Annual Report [10-K/A]

Is Nephros, Inc. (NASDAQ:NEPH) Potentially Undervalued?

Is Nephros, Inc. (NASDAQ:NEPH) Potentially Undervalued?

Nephros Expands Strategic Focus in Greater New York Market with Dedicated Regional Leadership

Nephros, Inc. Expands Regional Focus in Greater New York City with Appointment of Dana Cunningham as Sales Leader

Nephros Expands Strategic Focus in Greater New York Market with Dedicated Regional Leadership

Aging water systems push Nephros deeper into the New York market

Nephros Expands Water Safety Capabilities With ASSE 12080 Certified Water Management Planning Expertise

Nephros Expands Water Safety Capabilities With ASSE 12080 Certified Water Management Planning Expertise

Nephros Expands Water Safety Capabilities With ASSE 12080 Certified Water Management Planning Expertise

Nephros Expands Water Safety Capabilities With ASSE 12080 Certified Water Management Planning Expertise

Nephros Expands Water Safety Capabilities With ASSE 12080 Certified Water Management Planning Expertise

Nephros (Nasdaq:NEPH) - Stock Analysis

Nephros Expands Water Safety Capabilities With ASSE 12080 Certified Water Management Planning Expertise

Hospitals get a new water safety planning option from Nephros

NEPH PE Ratio & Valuation, Is NEPH Overvalued

About Nephros Inc

Classification

Company profile

NEPH

Market Comparison

NEPH Market Analysis

Overview

NEPH

Market Comparison

Fundamentals

Valuation

Profitability & growth

News & Sentiment

Nephros to Report First Quarter 2026 Financial Results on May 7

Nephros | 10-K/A: Annual report (Amendment)

Nephros schedules Q1 results after close, investor call at 4:30 ET

Nephros Schedules First Quarter 2026 Financial Results Conference Call

NEPHROS INC Amends Annual Report [10-K/A]

Is Nephros, Inc. (NASDAQ:NEPH) Potentially Undervalued?

Is Nephros, Inc. (NASDAQ:NEPH) Potentially Undervalued?

Nephros Expands Strategic Focus in Greater New York Market with Dedicated Regional Leadership

Nephros, Inc. Expands Regional Focus in Greater New York City with Appointment of Dana Cunningham as Sales Leader

Nephros Expands Strategic Focus in Greater New York Market with Dedicated Regional Leadership

Aging water systems push Nephros deeper into the New York market

Nephros Expands Water Safety Capabilities With ASSE 12080 Certified Water Management Planning Expertise

Nephros Expands Water Safety Capabilities With ASSE 12080 Certified Water Management Planning Expertise

Nephros Expands Water Safety Capabilities With ASSE 12080 Certified Water Management Planning Expertise

Nephros Expands Water Safety Capabilities With ASSE 12080 Certified Water Management Planning Expertise

Nephros Expands Water Safety Capabilities With ASSE 12080 Certified Water Management Planning Expertise

Nephros (Nasdaq:NEPH) - Stock Analysis

Nephros Expands Water Safety Capabilities With ASSE 12080 Certified Water Management Planning Expertise

Hospitals get a new water safety planning option from Nephros

NEPH PE Ratio & Valuation, Is NEPH Overvalued

About Nephros Inc

Classification

Company profile

NEPH

Market Comparison